Manufacturing of a Lyophilized Parenteral Dosage Form of the Indoloquinone Antitumour Agent EO9 for Phase II Clinical Studies in the Setting of a Hospital Pharmacy

J.D. Jonkman-de Vries; R.E.C. Henrar; A. Bult; J.H. Beijnen

Manufacturing of a Lyophilized Parenteral Dosage Form of the Indoloquinone Antitumour Agent EO9 for Phase II Clinical Studies in the Setting of a Hospital Pharmacy

J.D. Jonkman-de Vries, R.E.C. Henrar, A. Bult, J.H. Beijnen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	137-144
Number of pages	8
Journal	Drug Development and Industrial Pharmacy
Volume	23
Publication status	Published - 1997

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Public Health
Analytical chemistry
Drugmisbruik en verslaving

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{16817b2035324b188c13038df011d5e3,

title = "Manufacturing of a Lyophilized Parenteral Dosage Form of the Indoloquinone Antitumour Agent EO9 for Phase II Clinical Studies in the Setting of a Hospital Pharmacy",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Public Health, Analytical chemistry, Drugmisbruik en verslaving",

author = "{Jonkman-de Vries}, J.D. and R.E.C. Henrar and A. Bult and J.H. Beijnen",

year = "1997",

language = "Undefined/Unknown",

volume = "23",

pages = "137--144",

journal = "Drug Development and Industrial Pharmacy",

issn = "0363-9045",

publisher = "Informa Healthcare",

}

Manufacturing of a Lyophilized Parenteral Dosage Form of the Indoloquinone Antitumour Agent EO9 for Phase II Clinical Studies in the Setting of a Hospital Pharmacy. / Jonkman-de Vries, J.D.; Henrar, R.E.C.; Bult, A. et al.
In: Drug Development and Industrial Pharmacy, Vol. 23, 1997, p. 137-144.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Manufacturing of a Lyophilized Parenteral Dosage Form of the Indoloquinone Antitumour Agent EO9 for Phase II Clinical Studies in the Setting of a Hospital Pharmacy

AU - Jonkman-de Vries, J.D.

AU - Henrar, R.E.C.

AU - Bult, A.

AU - Beijnen, J.H.

PY - 1997

Y1 - 1997

KW - Medical technology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Public Health

KW - Analytical chemistry

KW - Drugmisbruik en verslaving

M3 - Article

SN - 0363-9045

VL - 23

SP - 137

EP - 144

JO - Drug Development and Industrial Pharmacy

JF - Drug Development and Industrial Pharmacy

ER -